Company thanks Sanjeev Narula for his role in the successful execution of Viatris Phase 1 strategy; Narula will support a smooth CFO transition prior to his departure on March 1, 2024
PITTSBURGH,.
Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Velji brings more than 20 years of experience in biotech financial servicesBASEL, Switzerland (BUSINESS WIRE) Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, today announced that Rizwan Velji has been appointe.
WINSTON-SALEM, N.C., Nov. 30, 2023 (GLOBE NEWSWIRE) ProKidney Corp. (NASDAQ:PROK) ("ProKidney"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.